MarketsNotableSingle-sourceDeveloping
5.1
Nuvalent, Inc. Files 8-K Reporting Change in Control and Corporate Restructuring
SEC EDGAR 8-K FilingsLO·US·2 days ago
Lipella Pharmaceuticals has filed for bankruptcy under Item 1.03 of an 8-K filing with the SEC. The filing indicates a formal insolvency process, signaling potential liquidation or restructuring of the firm's assets.
Locations
Entities